PT - JOURNAL ARTICLE AU - Geistlinger, Ludwig AU - Mirzayi, Chloe AU - Zohra, Fatima AU - Azhar, Rimsha AU - Elsafoury, Shaimaa AU - Grieve, Claire AU - Wokaty, Jennifer AU - Gamboa-Tuz, Samuel David AU - Sengupta, Pratyay AU - Hecht, Isaac AU - Ravikrishnan, Aarthi AU - Gonçalves, Rafael AU - Franzosa, Eric AU - Raman, Karthik AU - Carey, Vincent AU - Dowd, Jennifer B. AU - Jones, Heidi E. AU - Davis, Sean AU - Segata, Nicola AU - Huttenhower, Curtis AU - Waldron, Levi TI - BugSigDB captures patterns of differential abundance across a broad range of host-associated microbial signatures AID - 10.1101/2022.10.24.22281483 DP - 2023 Jan 01 TA - medRxiv PG - 2022.10.24.22281483 4099 - http://medrxiv.org/content/early/2023/07/18/2022.10.24.22281483.short 4100 - http://medrxiv.org/content/early/2023/07/18/2022.10.24.22281483.full AB - The literature of human and other host-associated microbiome studies is expanding rapidly, but systematic comparisons among published results of host-associated microbiome signatures of differential abundance remain difficult. We present BugSigDB, a community-editable database of manually curated microbial signatures from published differential abundance studies, accompanied by information on study geography, health outcomes, host body site, and experimental, epidemiological, and statistical methods using controlled vocabulary. The initial release of the database contains >2,500 manually curated signatures from >600 published studies on three host species, enabling high-throughput analysis of signature similarity, taxon enrichment, co-occurrence and co-exclusion, and consensus signatures. These data allow assessment of microbiome differential abundance within and across experimental conditions, environments, or body sites. Database-wide analysis reveals experimental conditions with the highest level of consistency in signatures reported by independent studies and identifies commonalities among disease-associated signatures including frequent introgression of oral pathobionts into the gut.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers 5R01CA230551 (to LW, NS, CH, and HJ) and 5U24CA180996 (to LW).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes